Code | 9749D | ||||||||||
MA number | EU/1/21/1612/005 | ||||||||||
Product Form: | sus inj 50x0,5 ml (striek.inj.napl.skl.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Pfizer Europe MA EEIG, Belgium | ||||||||||
Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Route of admin.: | Intramuscular use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 14.02.2022 |
Validity: | 14.02.2027 |
SmPC + PL: |
|
Safety feature | Yes |
Data update: | 13.03.2024 |